Literature DB >> 28661090

Rituximab-Resistant Nephrotic Syndrome With Successful Induction of Remission by Low-Density Lipoprotein Apheresis.

Hiroyuki Suzuki1, Tatsuo Tsukamoto1, Eri Muso1.   

Abstract

Entities:  

Keywords:  low-density lipoprotein apheresis; minimal change nephrotic syndrome; rituximab

Mesh：

Substances：

Year:  2017        PMID： 28661090     DOI： 10.1111/1744-9987.12561

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN： 1744-9979            Impact factor:   1.762


× No keyword cloud information.
  3 in total

Review 1.  Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.

Authors:  Shipra Agrawal; Joshua J Zaritsky; Alessia Fornoni; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2017-11-27       Impact factor: 28.314

2.  Low-Density Lipoprotein Apheresis in Patients with Acute Kidney Injury Due to Minimal Change Disease Requiring Acute Renal Replacement Therapy.

Authors:  Kohsuke Terada; Koji Mugishima; Sayuri Kawasaki; Fumiaki Itagaki; Takehisa Yamada; Yukinao Sakai
Journal:  Int J Nephrol Renovasc Dis       Date:  2020-06-18

Review 3.  IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome.

Authors:  Agnes Trautmann; Marina Vivarelli; Susan Samuel; Debbie Gipson; Aditi Sinha; Franz Schaefer; Ng Kar Hui; Olivia Boyer; Moin A Saleem; Luciana Feltran; Janina Müller-Deile; Jan Ulrich Becker; Francisco Cano; Hong Xu; Yam Ngo Lim; William Smoyer; Ifeoma Anochie; Koichi Nakanishi; Elisabeth Hodson; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2020-05-07       Impact factor: 3.714
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.